This sense that there is unfairness between the United States and our Western allies, mostly in Europe, who are paying much less for pharmaceuticals in the U.S. i think it's a fundamental issue of fairness for him. He tried to do this through a regulation in the first term, through a demonstration project at the Centers for Medicare and Medicaid Services that was struck down. In the second term he's begun to try to do that again. I think this may be an indication that they're having difficulty coming up with a regulatory framework that's going to pass judicial review. (00:53–01:01)
CLAIM
Asserts that a drug pricing regulation attempt was struck down in Trump's first term.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
